Abstracts and Awards - BCVS Scientific Sessions 2023
Bcvs 2023 abstract categories.
Submit your best science between January 11 – March 15, 2023
- Cardiac Regeneration, Stem Cells and Tissue Engineering
- Cardio-immunology and Inflammation
- Cardiovascular Therapeutics - NEW!
- Cell Death Mechanisms, Apoptosis, Necrosis and Autophagy
- Clinical/Translational Research
- COVID 19 in the Cardiovascular System
- Excitation-Contraction Coupling and Ion Channels and Arrhythmias
- Extracellular Vesicles and Exosome Biology - NEW!
- Genetics and Genomics of Cardiovascular Disease
- Human Cellular Models of Disease
- Inflammation, Thrombosis and Vascular Biology
- Mechanisms of Cardiac Remodeling, Hypertrophy and Failure
- Mechanisms of Heart Failure Preserved Ejection Fraction
- Mechanisms of Myocardial Fibrosis
- Mitochondria and Metabolism
- Myocardial Ischemia, Oxidative Stress, and Cardioprotection
- RNA and Cellular Regulation
- Sarcomeric Function and Contractility
- Sex-based Differences in Heart Disease - NEW!
- Signal Transduction Pathways
- Systems Approach to Cardiovascular Biology
- Transcriptional and Epigenetic Regulation of Gene Expression
Apply for BCVS 2023 Awards
- BCVS Cardiovascular Outreach Award
- BCVS Outstanding Early Career Award
- BCVS New Investigator Travel Award
Important Message to Abstract Submitters
The AHA has moved to a single sign-on process for submitting abstracts and disclosures through our website, Professional Heart Daily .
- Abstract submitters must have a username and password on Professional Heart Daily to complete their abstract submission when submitting to any AHA scientific meeting.
- If you do not remember your Professional Heart Daily login information or need to update your personal profile, do not create a new account. Please reach out to AHA Customer Service for assistance: AHA Customer Service (888) 242-2453 (Inside U.S.) (214) 570-5935 (Outside U.S.) Email: [email protected] Hours of Operation: Monday-Friday, 8 a.m. – 5 p.m. CT
- As the submitting author, please be prepared to provide all co-author emails.
- Co-authors without a complete disclosure will receive separate correspondence to submit this information.
Fellows Research Day - Abstract Submission Guidelines
ABSTRACT SUBMISSION DEADLINE: January 6, 2023, at 11:59 PM EST . The American Heart Association maintains the highest standards in acceptance and program development.
Abstract Submission: Please submit all abstracts at Fellows Research Day - Abstract Submission Form | American Heart Association no later than 11:59PM on January 6, 2023.
Eligibility Requirements for Submission of Abstracts:
Fellows enrolled in a clinical training program Residents enrolled in a clinical training program Medical students Postdoctoral fellows Graduate students Undergraduate students
Note : Non-tenured junior faculty are not eligible ot participate - only trainees. Also, individuals with a faculty appointment at the instructor level or higher are not eligible. Due to the anticipated volume of abstract submissions, there is a LIMIT OF (1) ABSTRACT SUBMISSION PER PERSON.
REGISTRATION IS FREE. The target of research can be anything broadly related to cardiovascular function and disease, including heart disease, vascular disease, and stroke. The range of disciplines appropriate for this event is BROAD and can include basic, translational, clinical, epidemiological, population, and bioengineering research. Participants may submit either of the following types of abstracts:
Identify major advances in key areas of cutting-edge research and technology in heart failure, atherosclerosis, stroke, cardiovascular genetics, molecular biology and arrhythmias.
Understand basic processes linking molecular and cellular biology and biochemistry with cardiovascular physiology and pathophysiology.
Recognize the promises and pitfalls of cell and gene therapy for cardiovascular disease.
Translate emerging clinical science to clinical practice in patients with cardiovascular disease and stroke.
Evaluate and implement new diagnostic and therapeutic strategies for treating cardiovascular disorders and stroke.
Note: If you do not know which category your abstract falls within, select 'Undeclared' on the abstract submission form and the Task Force will assign a category. Please follow the guidelines for abstract submission as outlined below:
Rules for Preparation and Submission of Abstracts
Fellows Research Day is an annual event designed to showcase the work of trainees in cardiovascular research.
Abstracts should be submitted from individuals currently in cardiovascular related training programs and students conducting cardiovascular related research.
Abstracts should be submitted for ongoing projects with preliminary data (not necessarily completed projects). Case reports will not be accepted.
The American Heart Association’s Fellows Research Day is a forum for the presentation of novel research findings. The work covered by the abstract must not have been published as a manuscript before the date and time of presentation. (January 6, 2023)
Previous presentations or acceptance of an abstract at a similar meeting does not preclude presentation at Fellow Research Day.
Abstract submission for Fellows Research Day does not preclude submission at national meetings.
Submission of an abstract constitutes a commitment by the Presenting Author to present it, if accepted.
Only electronic submissions will be accepted.
Due to the anticipated volume of abstract submissions, there is a limit of only (1) submission per person.
Expenses associated with the submission and presentation of an abstract are the responsibility of the presenter.
The Presenting Author is designated as the primary/submitting author. Fill in the information by typing into the boxes indicated.
Begin Other Author listing in the designated area. List first name, middle initial and last name of each author omitting degrees and titles.
You may rearrange the order of the authors; however, always list the senior author or mentor last.
Addition or deletions of author names are not permitted after 11:59 p.m., January 6, 2023.
Type of Abstract:
To ensure that your abstract receives proper scientific consideration, be sure to check off the appropriate category – Basic Science or Clinical Science. If unsure, check the box marked ‘Undeclared’ and the Fellows Research Day Task Force will determine the category.
An abstract must have a short, specific title that indicates the nature of the investigation. Use the title box provided on the form.
Do not use abbreviations in the title.
The title is limited to 250 characters. Spaces do not count as characters.
Submit all abstracts in English.
Authors should not “split” data to create several abstracts from one. If splitting is judged to have occurred, priority scores of related abstracts will be reduced.
Abstracts containing identical or nearly identical data submitted from the same institution and/or individuals will be disqualified.
To ensure that the abstract receives proper scientific consideration, please make sure that the abstract is submitted to the appropriate category.
Proofread abstracts carefully to avoid errors before submission. The abstract will be published exactly as it has been submitted.
In the abstract box, only provide the body of the abstract.
The abstract should contain the following headings in bold: Background, Hypothesis, Methods, Results and Conclusions.
Briefly describe objectives of the study unless they are contained in the title. Include a brief statement of methods if pertinent. State findings in detail sufficient to support conclusions.
Abstracts are limited to 1950 characters (about 300-350 words).
Abstracts should not describe research in which the chemical identity or source of the reagent is proprietary or cannot be revealed.
Use generic drug names.
Do not begin sentences with numerals.
Standard abbreviations may be used without definition. Nonstandard abbreviations (kept to a minimum) must be placed in parentheses after the first use of the word of phrase abbreviated.
Do not include references, credits or grant support.
Do not include the names or personal information of any patient participating in the study or trial.
After the January 6, 2023 deadline , abstracts may not be revised in any way or resubmitted. Proofread abstracts carefully to avoid errors before submission. If accepted, your abstract will be published as submitted.
Abstracts may be withdrawn by emailing the American Heart Association at [email protected] . However, there is no guarantee that the abstract may not be printed in the event’s program book.
Abstracts are selected on the basis of scientific merit and are randomly assigned as either ora l or poster presentations. Also, there will only be 76 abstracts selected in total.
Notification of acceptance of abstract will be emailed no later than January 27, 2023 .
Instructions for oral or poster presentations will be provided upon acceptance.
- All oral presentations must be in electronic format - preferably Windows based.
- All presentations and question-and-answer sessions will be conducted in English.
- Presenters may request assistance from the moderator who will repeat or rephrase questions from the audience or may ask a colleague in the audience to assist with translation.
Unauthorized recording of the AHA Fellows Research Day sessions is prohibited, whether by video, still or digital photography, audio or any other recording or reproduction mechanism. This includes recording of presentations and supporting A/V materials and of poster presentations and supporting poster materials.
The AHA reserves the right to all video or audio recordings of presentations at Fellows Research Day.
Last Reviewed: May 8, 2018
Up Next: AHA 2023 Conferences
AHA Cardiovascular Conferences: Promote your brand and drive qualified leads
Important information from the american heart association.
With everyone’s safety in mind, the American Heart Association has made the decision to convert the traditional format of the Vascular Discovery , QCOR , BCVS , Hypertension and Scientific Sessions 2020 Conferences into digital opportunities. The International Stroke Conference 2021 will also be an all virtual experience. AHA is committed to providing a solution to allow members and industry partners an opportunity to connect while remaining safe. AHA will continue to monitor this unprecedented health crisis in relation to other 2021 events.
Now a hybrid experience! -->
SCIENTIFIC SESSIONS 2023
November 10, 2023 | Pre-Sessions Symposia & Early Career Day November 11-13, 2023 |Philadelphia, PA + Virtual
Nov. 10-12, 2023 Sheraton Philadelphia Downtown, Philadelphia, PA
Target engaged resuscitation clinicians and researchers
INTERNATIONAL STROKE CONFERENCE 2024
Feb. 7-9, 2024, in Phoenix, Arizona
Phoenix Convention Center
Be part of the world’s largest meeting dedicated to the science and treatment of cerebrovascular disease.
Now a virtual experience! -->
February 28 – March 3, 2023 | Boston, MA Omni Boston Hotel at the Seaport
Extend your reach with cardiology professionals dedicated to Epidemiology & Prevention and Lifestyle and Cardiometabolic Health.
Now a digital destination! -->
July 31-Aug. 3, 2023 | Boston, MA Westin Boston Seaport District
Connect one-on-one with basic investigators promoting interaction among participants.
Sept. 7-10, 2023 | Boston, MA Sheraton Boston Hotel
Access more than 1,000 leaders in the field of hypertension at one of the most important medical meetings on the subject.
Showcase your brand with attendees interested in improving the quality of cardiac and stroke care.
May 11-13, 2023 | Boston, MA Boston Marriott Copley Place
Reach this targeted audience dedicated to Arteriosclerosis, Thrombosis and Vascular Biology and Peripheral Vascular Disease.
BEWARE OF DATA POACHERS AND FRAUDULENT WEBSITES. Exhibitatsessions.org is the only official website for exhibiting, advertising and sponsorships at any American Heart Association conferences. Please only purchase meeting assets from AHA corporate relations team members with “heart.org” emails, or from representatives of our only official sales vendor, Ascend Media, with “ascendmedia.com” emails. If you think you may have purchased any AHA conference asset from a fraudulent person or website, please contact [email protected] immediately.
Remember that AHA does not sell nor make available email addresses for registered meeting attendees. Any company contacting you claiming to have this information has obtained it by poaching publicly available data. AHA does NOT recommend the use of these services nor does AHA share attendee lists outside of its official postal mailing lists.
- AHA Communities
- Buy AHA Merchandise
In This Section
Call for Proposals
Submitting a Proposal
- Proposal Submission FAQs
- Creative Session Formats
Submit a Proposal (Online only; please read all meeting guidelines before beginning your submission)
Submit a Proposal link will be live later this fall; please read all meeting guidelines before beginning your submission.
If you encounter technical difficulties over the weekend, please e-mail technical support. All data entry issues reported before the deadline will be resolved.
Electronic submission only. The deadline for submitting proposals will be 11:59 p.m. PST, February 15, 2023 (07:59 GMT, February 15, 2023).
Deadline Extended until 11:59 PST (07:59 GMT), March 6, 2023.
This form is for submissions to the in-person annual meeting, which will take place in San Francisco from Thursday, January 4 through Sunday, January 7, 2024. Sessions accepted by the Program Committee for the in-person meeting will be scheduled from Thursday afternoon through Sunday morning.
Historians from the United States appearing on the program are required to be AHA members. Everyone on the program must register for the meeting when registration opens in the fall of 2023.
Affiliates with questions about submitting affiliate sessions should consult our affiliate page .
Before submitting a proposal online, session organizers should collect the following information, which will be needed to submit a complete proposal:
- Session title (of no more than 20 words)
- Session abstract (up to 500 words)
- Short session abstract for the meeting app (up to 50 words)
- Paper or presentation titles (if any)
- Abstract or description for each presentation (up to 300 words). Descriptions should be included for both roundtables and formal sessions.
- Biographical paragraph or CV summary (up to 250 words) for each participant
- Correct e-mail address for each participant
- Affiliation, city, state, and country for each participant
- Chair (required) and commentator (optional) for the session
- Organizer (required), serves as the principle point of contact but is not listed in the meeting program. Organizers are free to serve in other roles, which will be listed
- Audiovisual needs, if any
- Professional Twitter handle for each participant (optional)
- Website for each participant (optional)
- To assure substantial time for interaction between speakers and audience, panels are typically limited to a maximum of four participants in addition to a chair
Please Note: The Program Committee cannot accept single paper proposals.
Organizers submitting multi-session workshops will also be required to submit a brief description of the overall purpose and goals of the workshop. Organizers submitting experimental sessions will be asked to submit a 75-word description of the session format.
Organizers submitting poster proposals will need:
- Poster title
- Abstract of poster (up to 500 words)
- Poster abstracts should describe how poster will present information visually, as well as what the poster will argue intellectually
- Short abstract of poster for the meeting app (up to 50 words)
- Biographical paragraph or CV summary (up to 250 words)
For more information on crafting a poster proposal, take a look at our poster resources .
For detailed instructions and advice about using the online proposal system, consult the Frequently Asked Questions about the Submission of Proposals . Questions about policies, modes of presentation, and the electronic submissions process should be directed to the AHA staff .
To help members find sessions of interest, the online program for the annual meeting will include links to the abstracts for sessions and presentations entered into the electronic proposal system. The annual meeting app will include the short abstracts submitted with the proposal. Abstracts will be published as submitted to the Program Committee; individuals will not have the opportunity to edit abstracts after the proposal deadline. Please enter and review the information with that in mind.
Participants on accepted panels are expected to be available for all session slots, to the extent practicable. We can accommodate schedule requests based on religious practice, teaching schedules, ADA requests, and other obligations, which should be submitted with the proposal.
Presentation in Absentia
The AHA does not normally allow presentation via Skype, Zoom, or videoconference, as we find that it detracts from the experience for attendees, due to issues with sound quality and connectivity. It is also more difficult for the audience to interact with presenters who are not physically present. We do, however, allow presentations in absentia.
While we will not have high-speed internet capacity to support videoconferencing in the meeting space, we will offer a low-tech hybrid option for presenters unable to travel to the in-person meeting, in which presenters prerecord their presentation to be played during the session. Presenters may also elect to have another panelist read their presentation. Participants on affiliated society sessions should consult their affiliate for details.
Embargo Policy and Guidelines Table of Contents
- Embargo Policy for Journals-Statement-Guidelines-Scientific Meetings
- Who May Receive Embargoed Materials
- Acceptable media credentials for journalists / freelancers
- Who May NOT Receive Embargoed Materials
- Embargo Policy for News Media
- Guidelines for Video/Photography/Recording devices at AHA/ASA Scientific Meetings
- Guidelines for Researchers/ Scientists
- Guidelines for Medical Institutions / Universities / Health Organizations
- Guidelines for Industry / Company / Corporate Sponsors of Studies and their Public Relations Representatives
This document outlines the American Heart Association/American Stroke Association’s (AHA/ASA) embargo policy for:
- Studies published in AHA/ASA’s peer reviewed journals;
- AHA/ASA scientific statements, guidelines, science advisories and presidential advisories;
- Abstracts and late-breaking science abstracts/studies at AHA/ASA scientific meetings.
The embargo policy applies to the following audiences:
- News media;
- Study authors and writing group members;
- Medical institutions, health organizations and universities;
- Companies, corporate sponsors of studies and their public relations representatives.
Back to Top
AHA/ASA Embargo Policy for Journals-Statements-Guidelines-Scientific Meetings:
- AHA/ASA journal studies, statements, guidelines, scientific and presidential advisories : The embargo lifts at the time/date that the article is published either online or in print (whichever comes first).
- Non-late-breaking abstracts/studies presented at AHA/ASA scientific meetings: TBA for each meeting.
- Late-breaking science abstract/studies presented at AHA/ASA meetings: TBA for each meeting.
- Embargoes are clearly noted on all news media materials
International Stroke Conference 2023 Embargo Dates/Timing
Non-Late-Breaking Science abstracts for ISC 2023 and the Stroke Nursing Symposia
Embargoes lift at 4 a.m. CT/5 a.m. ET, Thursday, February 2, 2023 .
L ate Breaking Science (LBS) abstracts for ISC 2023
Embargoes lift at the start time of the first presentation in each Main Event, Wednesday, Thursday or Friday, Feb. 8, 9 and 10, 2023.
For questions regarding AHA/ASA’s embargo policy, contact the AHA Communications Department at [email protected] . Penalties for breaking an embargo will be assessed on a case-by-case basis. Circumstances of the embargo violation will be evaluated before a determination is made regarding appropriate penalties.
Who May Receive Embargoed Materials:
- News media reporters, writers, producers and editors with staff credentials from newspapers, magazines, online news services, wire services, radio or television networks, individual stations and blogs that appear on a media outlet's website that produce daily or weekly original health/medical/science news.
- Journalists with bylined news reports published on news wire services and news media who produce materials for bi-monthly, monthly, or quarterly publications or programs will be considered on a case-by-case basis. Reports should be original news stories, not article summaries of scientific materials.
- Freelance writers with approved credentials (must provide three bylined original news articles/clip links published by accredited media outlets within the past 6 months) and/or a verifiable assignment letter from an accredited media outlet. Letters of assignment must include contact information for the assigning editor at the media outlet. Note: access may be limited to the time of the specific freelance assignment.
- Bloggers who provide daily or weekly coverage of health news but are not affiliated with a major news outlet will be considered on a case-by-case basis.
- Writers/editors or contributors for websites not considered mainstream media but report regularly on breaking health news will be considered on a case-by-case basis. Staff/companies that produce Continuing Medical Education (CME) are not permitted to register for embargoed media access.
- All other applications will be considered on a case-by-case basis.
Acceptable media credentials for journalists/freelancers:
- National Association for Science Writers (NASW) membership card.
- International Science Writers Association (ISWA) membership card.
- Association of Health Care Journalists (AHCJ) membership card, plus an assignment letter from an accredited news organization.
- Assignment letter on official letterhead from an editor of a recognized publication or a producer of a recognized broadcast program certifying that reporter/freelancer is covering news for the respective organization.
- Government-issued press credentials and a letter of assignment from an accredited news organization.
- Official media-outlet-issued credentials/ID.
- Business cards will not be accepted as credentials.
Who may NOT receive Embargoed Materials:
- Industry representatives and financial/industry analysts.
- Staff/companies that produce Continuing Medical Education (CME) materials.
- Writers/editors or contributors for patient publications created and distributed by industry, such as pharmaceutical companies or device manufacturers.
- Staff from public relations firms, advertising agencies or production companies.
- Representatives of corporate, academic or hospital public relations/advertising/marketing/communications/media departments.
- Editors, writers of newsletters created and distributed by universities and hospitals for the public/patient/student.
- Hospitals/universities or other online sites reporting only their own news/press materials.
- In-house and/or industry newsletters/magazines/websites supported by industry or publications supported by a retail chain store, such as a drug store.
- Publishers (who are not reporters) of peer-reviewed medical journals and other media outlets that cover health news.
- Bloggers who do not report daily or weekly on breaking health news.
- Wire or other online services offering syndicated or mass distribution of AHA/ASA embargoed media materials to journalists and non-journalists.
- Staff or representative for medical education companies.
Embargo Policy for News Media:
- By accepting AHA/ASA embargoed materials through email, fax, regular mail, from the AHA’s online password-protected embargoed online newsroom site or via media registration for scientific meetings, reporters agree to follow the AHA/ASA embargo policies.
- AHA/ASA embargoed information is provided to facilitate the development of news content. Materials may not be published prior to the embargo time and can only be distributed to experts for media interviews. Journalists sharing information with expert sources bear the responsibility of ensuring those sources abide by all AHA policies.
- Failure to abide by AHA/ASA embargo policies may result in suspension of access to: AHA/ASA embargoed materials, media credentials at AHA/ASA scientific meetings and pre-embargo interviews with AHA/ASA volunteer experts. The media outlet that employs a reporter who has broken an embargo also may be penalized.
- Once a media outlet/reporter has been suspended, it is the responsibility of the reporter and/or media outlet to reapply to receive embargoed media materials after the suspension period ends.
Guidelines for video, photography and recording devices at AHA's scientific meetings:
- Only registered media - such as camera crews, producers and reporters - who have received their camera credentials upon registration are allowed to conduct interviews or shoot photos/videos at AHA/ASA scientific meetings.
Registered media may record video/take photographs in the following areas:
- The AHA News Media Center, including news briefings, conferences and broadcast interview rooms.
- Concourse areas, hallways and in select “main event” sessions.
- Registered media may record video of the daily Late-Breaking Science presentations from a lock-down position on a riser available for news media in the presentation hall.
- Only non-flash photography of speakers and their materials during oral or poster presentations is allowed by registered media.
Registered media may NOT record video/take photographs in the following areas:
- Science and Technology Exhibit Hall:
- In order to shoot flash photography or record video of a specific booth in the Science and Technology Exhibit Hall, advance permission must be given by booth manager and the AHA exhibits manager who will provide an escort for the media crew.
- Media who want to record general b-roll or photos of the HeartQuarters booth may do so with advance permission from News Media Center staff and an escort. Limited dates/times will be noted on news media website.
- Recording video interviews is prohibited in the Science and Technology Exhibit Hall and must be conducted outside of the Hall.
- No video recording is allowed in meeting rooms or poster sessions. Only still (no flash) photographs may be taken of a specific poster with the author’s permission.
- Still (no flash) photographs or audio recordings for commercial use taken in meeting rooms require advance consent by the AHA and the speaker/presenter.
Any questions about recording video/photography in any of the restricted areas should be addressed with the AHA/ASA Scientific Meeting registration staff.
Guidelines for researchers and scientists of studies to be published in AHA/ASA journals or presented at an AHA/ASA scientific meeting:
Note: The rules below apply to all studies published in AHA/ASA peer reviewed journals and all abstracts/studies presented at AHA/ASA meetings, whether or not the AHA/ASA is promoting them to the news media.
- Abstracts or manuscripts accepted for presentation at an AHA/ASA scientific meeting or to be published in an AHA/ASA journal may not be presented at other meetings or published in other journals prior to the embargo time set by the AHA/ASA.
- All authors, researchers and institutions associated with a manuscript being published in an AHA/ASA journal or an abstract being presented at an AHA/ASA meeting must comply with the AHA/ASA embargo policy .
- Study/abstract authors may not distribute any embargoed written information (slides, manuscript, etc.) to the news media prior to the embargo date and time. Reporters may contact the AHA/ASA communications department to get copies of manuscripts and/or abstracts.
- Study and abstract authors are allowed to conduct embargoed media interviews as long as the embargo date and time are emphasized to the news media.
- Researchers who are presenting their study in an AHA/ASA embargoed media briefing or news conference may bring one co-author of the study as a guest to the AHA/ASA media event. Corporate sponsor representatives are not allowed in any AHA/ASA media events at AHA/ASA scientific meetings.
- Researchers/healthcare professionals who are members of an AHA/ASA Scientific Statement/Guidelines Writing Committee are not allowed to share any information, including the fact that there is a document in progress, about the content of the statement/guideline with the news media, colleagues or institution prior to the AHA’s Communications department issuing an embargoed news release.
- If the news media breaks an embargo as a result of a researcher conducting an embargoed interview or as the result of their public relations department/agency/institution providing them with written or visual information, the researcher risks having the study pulled from the AHA journal or pulled from being presented at an AHA/ASA scientific meeting. Embargo breaks in these cases will be reviewed on a case-by-case basis.
- Failure to honor embargoes may also jeopardize future acceptance of studies and/or exhibition at AHA/ASA scientific meetings or acceptance of manuscripts for publication in AHA/ASA journals.
Guidelines for Medical Institutions / Universities / Health Organizations:
- Studies published in AHA/ASA journals and non-late-breaking abstracts presented at an AHA/ASA scientific meeting: Universities, medical institutions and health organizations that are involved in a study may distribute their own embargoed news release 2 business days prior to the embargo and authors of studies and representatives from the institution may conduct embargoed media interviews during the 2-day pre-embargo period. However, no one other than AHA/ASA is allowed to issue embargoed media materials pertaining to scientific statements, guidelines or late-breaking science prior to embargo. (See Description of Embargo Policies for specific information on time of embargoes.)
- Researchers may conduct pre-embargo interviews with reporters based on news materials provided by the AHA/ASA or the institution.
- Universities, medical institutions and health organizations that have information being presented at an AHA/ASA scientific meeting may not conduct any planned embargoed promotional media activities, such as media briefings/news conferences, satellite media tours, corporate receptions, or investigator meetings before the embargo lifts.
- If media break an embargo as a result of issuing information or conducting an interview, the AHA/ASA may enforce sanctions against the reporter/media outlet, the researcher/scientist and university/institution/company as appropriate.
- The full name of the study;
- The first and last authors’ names as they are listed on the study; and
- The name of the journal where it is being published or the name of the meeting where it is being presented.
- Please send this information to AHA/ASA Communications at [email protected] .
- AHA/ASA does not approve or review news material content developed by universities/medical institutions but does need to be aware of promotion plans in case they receive media queries.
- AHA/ASA requests that the universities/medical institutions include the name of the AHA journal where the study is being published or the name of the AHA/ASA’s scientific meeting where the study is being presented in their news release – such as “publishing in the American Heart Association’s flagship journal Circulation on [date, time]” or “to be presented at the American Heart Association’s 2020 Scientific Sessions, on [date, time]”.
- Universities, medical institutions and health organizations must obtain specific study information, including the embargo date/time, from the researcher. AHA/ASA will not provide anyone with study information unless the researcher contacts the AHA/ASA staff asking them to provide the information.
- Only the presenter/lead author of the study and one co-author of the study may attend an AHA/ASA embargoed media briefing or news conference at a scientific meeting. The co-author’s name must be listed on the abstract.
- Researchers/healthcare providers who are members of an AHA/ASA Scientific Statement/Guidelines Writing Committee are not allowed to share any information, including the fact that there is a document in progress, about the content of the statement/guideline with the news media, colleagues or institution prior to the AHA’s Communications department issuing an embargoed news release.
- AHA/ASA statements and guidelines represent AHA/ASA positions. Therefore, institutions and universities may not issue embargoed news releases to promote their faculty member’s participation as a member of the writing group until the embargo has lifted.
Guidelines for Industry / Company / Corporate Sponsors of Studies and their Public Relations Representatives:
- Pharmaceutical companies, device manufacturers or companies that are corporate sponsors of a study and/or their representatives are not permitted to issue embargoed news releases, statements or proactively promoting their spokespeople prior to embargo.
- Pharmaceutical companies, device manufacturers or companies that are corporate sponsors of a study and their representatives are not permitted to conduct any type of event where media are in attendance prior to embargo.
- Pharmaceutical companies, device manufacturers or companies that are corporate sponsors of a study and their representatives are permitted to make representatives available to answer only incoming inquiries from the media after the embargo lifts.
- If a company feels that for legal reasons it is obligated to release information about a study prior to the embargo, the company must notify AHA/ASA in advance in writing regarding the legal rationale as to why the information must be disclosed, and advise specifically who would receive the information, how/when the information would be disclosed and exactly what information would be released. AHA/ASA then will determine whether the study shall remain on the program of an AHA/ASA meeting or be published in an AHA/ASA scientific journal. One specific consideration will be whether the company plans to release qualitative information (i.e., the primary endpoint was/was not met) rather than quantitative data (specific study results). Please send this information to: [email protected] .
- Representatives from public relations agencies or companies involved in a study are not permitted to attend embargoed media briefings or news conferences at AHA/ASA scientific meetings. The only exception is when a representative of a company is an author listed on an abstract of a study being presented in an AHA/ASA embargoed media briefing or news conference.
- Media interview rooms are for the use of media only. PR representatives from pharmaceutical and device companies are allowed in the room only if specifically invited by a credentialed journalist. PR representatives are not allowed to use the media rooms for their activities and must conduct their work elsewhere.
- Industry and exhibitor events for the news media are not permitted during AHA/ASA’s scientific meeting operating hours. Permission for officially-sanctioned satellite events must be obtained from AHA scientific meetings staff. Media cannot be invited and are not permitted to attend investigator meetings. Violating this policy is considered an embargo break and penalties apply.
- Company representatives are not permitted to pass out literature, statements or news releases in or around the adjacent hallways and areas of the News Conference/Media Briefing Room and the New Media Newsroom.
- AHA does not share its media list with anyone. Companies are responsible for distributing their media materials to the news media at time of embargo and are not allowed to put their media materials in the AHA/ASA media area at AHA/ASA scientific meetings.
- Companies that have questions about issuing news releases should contact the AHA Communications dept. at 214-706-1173 or [email protected] .
If you have additional questions, please contact the American Heart Association’s Communications team: [email protected] . Please note: all inquiries must be submitted in writing via email.
Abstracts From the American Heart Association's 2022 Scientific Sessions AHA Journal & Editor Events at AHA Scientific Sessions 2022 ATVB: Identifying and Practicing Emerging Genomic Based Therapies on Cardiovascular Disease Room: Main Event III AT.ME.148 - November 5, 2022, 4:30 PM - 5:30 PM
abstract are placed after the abstract that will appear in the online-only supplement to Circulation, an American Heart Association journal. Abstract Acceptance • Guidelines for abstract presentation will be provided to the presenting author of accepted abstracts in mid-August via email.
The AHA has moved to a single sign-on process for submitting abstracts and disclosures through our website, Professional Heart Daily. Abstract submitters must have a username and password on Professional Heart Daily to complete their abstract submission when submitting to any AHA scientific meeting.
Table of Contents November 16, 2021 - Volume 144, Issue Suppl_1: Abstracts From the American Heart Association's 2021 Scientific Sessions Acute Coronary Syndromes (121) Arteriosclerosis, Thrombosis, Vascular Biology (222) Cardiac Development, Structure and Function (90) Cardio-Oncology (91) Cardiometabolic Health and Diabetes (82)
ABSTRACT SUBMISSION DEADLINE: January 6, 2023, at 11:59 PM EST. The American Heart Association maintains the highest standards in acceptance and program development. Abstract Submission: Please submit all abstracts at Fellows Research Day - Abstract Submission Form | American Heart Association no later than 11:59PM on January 6, 2023.
Exhibitatsessions.org is the only official website for exhibiting, advertising and sponsorships at any American Heart Association conferences. Please only purchase meeting assets from AHA corporate relations team members with “heart.org” emails, or from representatives of our only official sales vendor, Ascend Media, with “ascendmedia.com” emails.
The annual meeting app will include the short abstracts submitted with the proposal. Abstracts will be published as submitted to the Program Committee; individuals will not have the opportunity to edit abstracts after the proposal deadline. Please enter and review the information with that in mind.
This document outlines the American Heart Association/American Stroke Association’s (AHA/ASA) embargo policy for: AHA/ASA scientific statements, guidelines, science advisories and presidential advisories; Abstracts and late-breaking science abstracts/studies at AHA/ASA scientific meetings.